HB Wealth Management LLC Has $413,000 Holdings in Centene Co. (NYSE:CNC)

HB Wealth Management LLC decreased its position in shares of Centene Co. (NYSE:CNC) by 13.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,812 shares of the company’s stock after selling 1,069 shares during the quarter. HB Wealth Management LLC’s holdings in Centene were worth $413,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Mount Yale Investment Advisors LLC grew its holdings in shares of Centene by 2.1% during the third quarter. Mount Yale Investment Advisors LLC now owns 8,082 shares of the company’s stock worth $608,000 after purchasing an additional 167 shares during the last quarter. Aptus Capital Advisors LLC grew its holdings in Centene by 6.2% during the 3rd quarter. Aptus Capital Advisors LLC now owns 3,722 shares of the company’s stock worth $280,000 after acquiring an additional 217 shares during the last quarter. CX Institutional increased its position in Centene by 7.3% in the 3rd quarter. CX Institutional now owns 3,919 shares of the company’s stock valued at $295,000 after acquiring an additional 266 shares during the period. Forte Capital LLC ADV raised its stake in shares of Centene by 5.5% during the third quarter. Forte Capital LLC ADV now owns 5,320 shares of the company’s stock valued at $400,000 after acquiring an additional 275 shares during the last quarter. Finally, GAM Holding AG grew its stake in shares of Centene by 0.3% in the third quarter. GAM Holding AG now owns 88,973 shares of the company’s stock worth $6,698,000 after purchasing an additional 288 shares during the last quarter. Institutional investors own 93.63% of the company’s stock.

Insider Buying and Selling at Centene

In related news, Director Thomas Greco acquired 17,000 shares of the stock in a transaction on Wednesday, December 18th. The stock was acquired at an average price of $59.75 per share, for a total transaction of $1,015,750.00. Following the completion of the purchase, the director now owns 19,309 shares of the company’s stock, valued at $1,153,712.75. This represents a 736.25 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director H James Dallas acquired 1,693 shares of Centene stock in a transaction on Monday, December 16th. The shares were purchased at an average price of $59.01 per share, with a total value of $99,903.93. Following the completion of the purchase, the director now owns 1,693 shares in the company, valued at $99,903.93. This represents a ? increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders have bought 45,010 shares of company stock worth $2,660,276. 0.33% of the stock is currently owned by company insiders.

Centene Stock Up 2.5 %

Shares of NYSE CNC opened at $65.15 on Friday. The stock has a market capitalization of $32.89 billion, a P/E ratio of 11.31, a PEG ratio of 0.85 and a beta of 0.45. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.10 and a quick ratio of 1.10. Centene Co. has a one year low of $55.03 and a one year high of $81.42. The firm’s 50 day simple moving average is $60.36 and its two-hundred day simple moving average is $67.26.

Wall Street Analysts Forecast Growth

CNC has been the topic of several recent research reports. Jefferies Financial Group downgraded Centene from a “hold” rating to an “underperform” rating and cut their target price for the stock from $68.00 to $52.00 in a report on Tuesday, December 10th. Robert W. Baird reduced their target price on Centene from $83.00 to $66.00 and set a “neutral” rating on the stock in a report on Friday, October 25th. UBS Group upgraded shares of Centene from a “neutral” rating to a “buy” rating and raised their price target for the stock from $79.00 to $80.00 in a report on Friday, December 13th. Wells Fargo & Company reduced their price objective on shares of Centene from $91.00 to $90.00 and set an “overweight” rating on the stock in a research note on Monday, November 4th. Finally, Truist Financial lowered their target price on shares of Centene from $89.00 to $84.00 and set a “buy” rating for the company in a research note on Friday, December 13th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and ten have given a buy rating to the company’s stock. According to MarketBeat.com, Centene has a consensus rating of “Moderate Buy” and an average target price of $80.92.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.